English Archives - Sidra Medicine

Ola Shalaby

Dr. Ola Shalaby is an Attending Physician specializing in General and Obstetric Anesthesiology at Sidra Medicine, where she has been serving since January 2025. With a strong commitment to patient safety and comfort, Dr. Shalaby expertly administers anesthesia for a wide range of obstetric and gynecological procedures.

Known for her compassionate approach and meticulous attention to detail, Dr. Shalaby is dedicated to providing exceptional, patient-centered care tailored to the unique needs of her diverse patient population. She has a particular interest in obstetric anesthesia, bariatric anesthesia, high-dependency care, and critical care. Additionally, she is actively involved in education and training to advance clinical excellence in anesthesiology.

05 May, 2025

Sidra Medicine Study Pioneers Genome Assembly Approach for Rare Disease Research

Researchers at Sidra Medicine, a member of Qatar Foundation, have led a landmark study, published in Nature Genetics, unlocking the genetic causes of difficult-to-resolve rare diseases from diverse Middle Eastern populations.

03 May, 2025

Sidra Medicine to Host Inaugural MENA ART Conference

Advancing Precision Medicine with Flow Cytometry and Optical Microscopy 3 May 2024, Doha, Qatar - Sidra Medicine, a member of Qatar Foundation, will host its inaugural MENA ART (Advanced Research

30 April, 2025

Sidra Medicine and Children’s Hospital Los Angeles Sign Memorandum of Understanding

Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MOU) with Children’s Hospital Los Angeles (CHLA), marking the beginning of a new collaboration between the two leading pediatric healthcare institutions.

29 April, 2025

Sidra Medicine Zebrafish Study Investigates Gene Linked to Autism and Epilepsy

Sidra Medicine and Qatar Biomedical Research Institute (QBRI) at Hamad Bin Khalifa University, have published a groundbreaking study marking the first creation of an autism zebrafish model in Qatar, to investigate a rare genetic mutation associated with both autism and epilepsy. The study highlights the power of precision medicine in advancing our understanding of complex neurodevelopmental disorders.

20 April, 2025

Sidra Medicine Signs MoU with Vitafluence.ai to Advance AI-Driven Healthcare Innovation

Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MOU) with Germany-based Vitafluence.ai GmbH and its Swiss venture studio, EmpathicAI.Life, to explore potential collaborations in the field of artificial intelligence (AI) and digital health innovation.

17 April, 2025

Sidra Medicine Appoints Prof. Ibrahim Janahi as Chief Medical Officer

Sidra Medicine, a member of Qatar Foundation, has appointed Prof. Ibrahim Janahi as its new Chief Medical Officer (CMO). A distinguished leader at the Sidra Medicine, Prof. Janahi has previously

15 April, 2025

Msheireb Museums and Sidra Medicine host Science Café on Autism on the sidelines of the AutismTech Conference

Msheireb Museums and Sidra Medicine, entities of Qatar Foundation, presented the second session of the popular Science Café Series on Monday at Bin Jelmood House. Titled "Autism and Neurodiversity: From Breakthroughs to Real-Life Journeys," the session was specifically arranged to coincide with World Autism Month and the AutismTech Conference hosted by Hamad Bin Khalifa University.

14 April, 2025

Sidra Medicine to Host AI and Medicine 2025 Conference

Sidra Medicine, a member of Qatar Foundation, will host the second edition of its international conference, Artificial Intelligence (AI) and Medicine 2025, from 23 to 26 April 2025.

07 April, 2025

Sidra Medicine Highlights Advanced Maternity Research and Neonatal Care on World Health Day

Sidra Medicine, a member of Qatar Foundation, marks World Health Day with highlights from its Neonatal Intensive Care Unit (NICU) and a recent microbiome study on preterm birth from its Research division.